R&D
WASHINGTON BIOTECHNOLOGY, INC.
In Vivo Contract Research
INFLAMMATION For 20 years, Washington Biotechnology, Inc., a US FDA-registered and inspected CRO with facilities located
ARTHRITIS
in Columbia, Maryland, has provided expert in vivo testing services to the global biopharmaceutical and
biotechnology communities.
CANCER
We offer a comprehensive array of in vivo services for efficacy testing including therapeutic and prophylactic
BACTERIAL
models especially relevant to drug or vaccine development for immuno-inflammatory disorders such as
INFECTION
arthritis, asthma and diabetes.
VIRAL INFECTION
For cancer studies, Washington Biotechnology has an in-house library of cell lines for validated xenograft
PHARMACOKINETICS
mouse models. Our services include subcutaneous xenograft, orthotopic and syngeneic models.
TOXICITY
Our approach to your study merges accuracy in science with attentive project management to include:
MTD
complimentary consulting services; custom protocols designed to meet your needs; rapid scheduling and start-
up; a highly experienced project management team; frequent reporting of data and project status information;
SAFETY
and final reports prepared to US FDA standards.
GLP & NON-GLP
For further information, please visit www.WashingtonBiotech.com or contact Sean O’Neill, PhD at wbio@erols.com.
IN VITRO SERVICES
Washington Biotechnology, Inc. - Your resource for in vivo accuracy www.WashingtonBiotech.com
One Shot
W
fi
ashington Biotechnolog
nale 128x185 4
y
/
, Inc.
03/
9075 Guilford Road Columbia,
05 15:58 Page 1
MD 21046 USA Tel: +1-301-617-9901 Fax: +1-301-617-9904
Contract Research in Animal Pharmacology
With over two decades of CRO experience, we provide high quality
services in animal pharmacology to the worldwide pharmaceutical and
biotechnology communities.
Your direct access to our highly experienced and friendly staff helps advance
your projects, with expert advice and tailored solutions.
Together, we can build lasting relationships in full confidence.
The same people will be there the next time you need them.
We offer a wide range of animal models designed to evaluate the efficacy
and safety of novel pharmaceuticals. Our test portfolio has steadily grown
CNS PHARMACOLOGY & PAIN
over the years, integrating new scientific knowledge and the needs of the
CARDIOVASCULAR PHARMACOLOGY
pharmaceutical industry. Our 2 500 sqm of research laboratories include
RESPIRATORY PHARMACOLOGY
the latest technological advances and are compliant with international
GASTRO-INTESTINAL PHARMACOLOGY
regulatory requirements.
RENAL & UROGENITAL PHARMACOLOGY
METABOLISM
PHARMACOKINETICS
Porsolt & Partners Pharmacology
For further information, please visit www.porsolt.com or contact Martine Lemaire PharmD, PhD.
9 bis rue Henri Martin, 92100 Boulogne-Billancourt, France • Telephone +33 1 46 10 99 90 • Fax +33 1 46 10 99 99 • E-mail contact
@
porsolt.com
www.scripnews.com/supplements Scrip 100
37
Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128